BenevolentAI Investor Conference Presentation Deck
KEY SHAREHOLDER
INFORMATION
Listed on EuroNext; April 2022
REAKOU (Euronext Amsterdam: BAI)
Offices in London, NYC and
laboratories in Cambridge UK
c.260 employees
as at 31 December 2023
Top Shareholders (Dec'23):
Ken Mulvany (co-founder) - 27.3%
Temasek Life Sciences - 14.8%
Link - 7.3%
Zaoui - 7.3% (Odyssey sponsors)
Ally Bridge Group - 5.9%
Lansdowne Partners - 4.6%
Evenstad Family - 4.4%
Schroders - 3.8%
Michael Brennan - 3.7%
ACME Tools - 3.0%
Strategic/partnership shareholders:
Lilly 2.2%
AstraZeneca
1.8%
BOARD
Dr. François Nader
Acting CEO & Chair
ELT
Prof Sir Nigel
Shadbolt
Non-Executive Director
Dr. François Nader
Acting CEO & Chair
Dr. Daniel Neil
CTO
Jean Raby
Non-Executive & Senior
Independent Director
Dr. John Orloff
Non-Executive Director
Dr. Ivan Griffin
Co-Founder
Christina Busmalis
CRO
Dr. Olivier Brandicourt
Non-Executive Director
Marcello Damiani
Non-Executive
Director
Catherine Isted
CFO
Anna
Fullerton-Batten
CPO
Dr. Susan Liautaud
Non-Executive Director
Dr. Anne Phelan
CSO
Will Scrimshaw
General Counsel
Benevolent 14View entire presentation